tradingkey.logo

Gilead falls after co forecasts 2026 profit below estimates

ReutersFeb 10, 2026 9:18 PM

Shares of drugmaker Gilead GILD.O fall 6% to $138.35 after market

Co forecasts 2026 adjusted profit to be in the range of $8.45 to $8.85 per share, the midpoint of which is below analysts' estimates of $8.74 per share — LSEG data

Forecasts 2026 sales to be about $29.6 billion to $30 billion, compared to consensus estimate of $30.2 billion

Co's Q4 results came in slightly above Wall Street estimates

Co says it trimmed its outlook for 2026 sales growth by about 2% due to a pricing agreement with the Trump administration and uncertainty about the number of people who will retain insurance coverage under Affordable Care Act plans now that some government subsidies have expired

GILD was up 32.8% in 2025

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI